MedPath

the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of Oocyte on Poor Ovarian Response(POR)

Not Applicable
Completed
Conditions
Poor Ovarian Response
Interventions
Other: TEAS
Registration Number
NCT03994614
Lead Sponsor
ShangHai Ji Ai Genetics & IVF Institute
Brief Summary

Patients in experimental group will be given transcutaneous electrical acupoint stimulation (TEAS) treatment for 12 weeks prior to controlled ovarian stimulation (COS).The patients will be given three times acupuncture every week except menstruation.Patients in no intervention group will not be given any interventions for 12 weeks prior to COS. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes.

Detailed Description

The patients will be randomly recruited into two groups. Patients in experimental group will be given TEAS treatment for 12 weeks prior to COS.The patients will be given three times acupuncture every week except menstruation. One treatment lasts for 30 minutes. The acupoints used for the TEAS treatment included head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26). Patients in no intervention group will not be given any intervention for 12 weeks prior to COS. When at least one dominant follicle is greater than 18 mm then injection a GnRH agonist (Triptorelin, Ferring, Switzerland) 0.2mg. 36 hours later transvaginal oocyte retrieval will be taken. After 3 hours of incubation, each egg will be transferred with a density of about 100,000/mllive sperm. The fresh embryo transfer is performed 72 hours after embryo culture in vitro. The whole embryos will be frozen.

The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes,including basic endocrine, serum Anti-Mullerian Hormone (AMH), antral follicle counts, fertilization rate, cleavage rate, number of D3 embryos, the clinical pregnancy rate and early abortion rate.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
92
Inclusion Criteria
  1. The poor ovarian response patients compliance with Bologna consensus
  2. Age:20-45 year
  3. Women undergoing IVF-ET because of infertility for more than one year.
Exclusion Criteria
  1. Patients with genital tract malformation. Uterine malformation (single uterus, double uterus, double uterus, untreated mediastinal uterus) and other effects affecting uterine cavity disease (adenomyosis, submucosal uterine fibroids, intrauterine adhesions and scar uterus)
  2. Complicated with other medical diseases(Hypertension, diabetes, psychosis, hereditary diseases)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
the TEAS intervention groupTEASPatients in this group will be given TEAS treatment for 12 weeks prior to COS.
Primary Outcome Measures
NameTimeMethod
The number of MII eggsone day after oocyte pickup

The number of MII eggs obtained in the COS cycle

Secondary Outcome Measures
NameTimeMethod
cleavage ratecleavage rate calculated on 2 days after oocyte pickup

cleavage rate

Basic Follicle stimulating hormone (FSH) valueOn Day two of menstruation

Basic FSH value in mIU/ml

the number of Day 3 embryosthe number of Day 3 embryos calculated on 3 days after oocyte pickup

the number of Day 3 embryos

clinical pregnancy rateclinical pregnancy rate calculated on the 6th gestational week

clinical pregnancy rate

antral follicle countantral follicle count On Day two of menstruation

antral follicle count

fertilization ratefertilization rate calculated on 1 day after oocyte pickup

fertilization rate

early abortion rateearly abortion rate calculated on 12th week of pregnancy

early abortion rate

Basic estrodiol valueOn Day two of menstruation

Basic estrodiol in pg/ml

Serum AMH valueOn Day two of menstruation

Serum AMH in ng/ml

Basic Luteinizing hormone (LH) valueOn Day two of menstruation

Basic LH in mIU/ml

Trial Locations

Locations (1)

Shanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecology Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath